A bipartisan group of legislators (you read that correctly: bipartisan) introduced a bill in the House of Representatives last week that would require the FDA to regulate cannabidiol (CBD) in foods and beverages.
"The CBD Product Safety and Standardization Act of 2021" was introduced by Rep. Kathleen Rice, a Democrat from New York, along with Reps. Angie Craig (D-Minn.), Morgan Griffith (R-Va.) and Dan Crenshaw (R-Texas).
“CBD products are exploding in popularity, but the lack of federal regulation surrounding them has put consumers at risk and left businesses looking for clarity,” said Rice. “The bipartisan CBD Product Safety and Standardization Act will establish the clear regulatory framework needed to provide stability for business and ensure unsafe products stay off the shelves."
It calls on FDA, "through notice and comment rulemaking," to determine "(1) a maximum amount of cannabidiol derived from hemp per serving; (2) labeling and packaging requirements; and (3) conditions of intended use."
Back in May, a bipartisan trio of U.S. senators introduced in that chamber "The Hemp Access and Consumer Safety Act, " a similar bill to allow CBD use in foods and beverages. That bill remains in the Senate's Health, Education, Labor and Pensions committee.
Despite the ubiquity of CBD-containing products and their apparent legality in some states, FDA has prohibited them in interstate commerce and has not recognized the ingredient as "generally recognized as safe."
